[27G-am] Therapeutic drug monitoring (TDM) and administration plans

Sun. Mar 27, 2022 10:30 AM - 11:42 AM [Room G] Exhibition Room 212 (Bldg. 2: 1F)

Chair: Yuji Hotta

+Add all to schedule

10:30 AM - 10:42 AM

[27G-am06] Application of previously reported tadalafil population pharmacokinetic model to therapeutic drug monitoring in Japanese pediatric patients with pulmonary arterial hypertension

○Akari Minami^1,2, Kenji Okada^1,2, Ami Kaminuma², Takuya Wakamiya³, Takeshi Ikegawa³, Syun Kawai³, Shin Ono³, Ki-Sung Kim³, Sadamitsu Yanagi³, Hideaki Ueda³, Takashi Yoshikado^1,2, Mikako Oka^1,2, Koji Chiba^1,2 (1. Grad. Sch. Pharm. Sci., Yokohama Univ. Pharm, 2. Yokohama Univ. Pharm, 3. Kanagawa Child Med Center)

10:42 AM - 10:54 AM

[27G-am07S] Evaluation of pediatric arbekacin dosage and administration using reported pediatric population pharmacokinetic model of arbekacin

○Yosuke Kobayashi¹, Kenji Okada¹, Ayumu Kusano², Yuki Hanai², Takayoshi Kosugi³, Takashi Yoshikado¹, Mikako Oka¹, Koji Chiba¹ (1. Pharm. Yokohama Univ., 2. Omori Med. Ctr., Toho Univ., 3. Nati. Def. Med. Col.Hosp.)

10:54 AM - 11:06 AM

[27G-am08S] Relationship between TDM implementation for arbekacin and calculating reimbursement related to pharmacist interventions or infection based on Japanese large medical claims database

○Saki Ito¹, Ryo Inose¹, Ryota Goto¹, Moeno Ichii¹, Misato Shimoki¹, Yuichi Muraki¹ (1. Kyoto Pharmaceutical University)

11:06 AM - 11:18 AM

[27G-am09S] Implementation status of voriconazole therapeutic drug monitoring: analysis of data from a large Japanese health insurance claims database

○Takayuki Miyai¹, Shungo imai², Kenji Momo³, Hitoshi Kashiwagi², Yuki Sato², Mitsuru Sugawara^2,4, Yoh Takekuma⁴ (1. Grad. Sch. Life Sci., Hokkaido Univ., 2. Fac. Pharm. Sci., Hokkaido Univ., 3. Sch. Pharm., Showa Univ., 4. Dept. pharm., Hokkaido Univ Hosp.)

11:18 AM - 11:30 AM

[27G-am10] Clinical applicability of measured creatinine clearance for determining the initial dose of vancomycin in critically ill patients

○Ryusei Mikami¹, Shungo Imai², Mineji Hayakawa³, Mitsuru Sugawara^1,2, Yoh Takekuma¹ (1. Dept. Pharm., Hokkaido Univ Hosp., 2. Fac. Pharm. Sci., Hokkaido Univ., 3. Dept. Emergency., Hokkaido Univ Hosp.)

11:30 AM - 11:42 AM

[27G-am11S] Population pharmacokinetic model and dosing simulation of meropenem using measured creatinine clearance in patients with sepsis : Maximally effective dosing regimens of meropenem based on renal function

○Shiori Fukumoto¹, Masayuki Ohbayashi², Akira Okada³, Noriko Kohyama², Tatsuro Tamatsukuri⁴, Hideki Inoue⁵, Akihito Kato⁶, Toru Kotani⁷, Hironori Sagara⁵, Kenji Dohi⁶, Mari Kogo² (1. Grad.SCh.pharm.,Showa Univ., 2. SCh.pharm.,Showa Univ., 3. Sch.pharm.,Musashino, 4. Pharm,Showa University Hospital, 5. Department of Medicine,Divison of Respiratory medicine and Allergy,Showa University Hospital, 6. Department of Emergency,SCh.med.,Showa University , 7. Department of Intensive Care Medicine,SCh.med.,Showa University )

Session information